Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse: NANOPRO, a Non-randomized Phase II Study

NCT04784221 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT04784221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04784221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse: NANOPRO, a Non-randomized Phase II Study
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2021
Completion date
September 30, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

previous radiation, recurrent cancer